Article
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques
21 Sept 2017
Abstract excerpt
The development of an effective AIDS vaccine has been challenging because of viral genetic diversity and the difficulty of generating broadly neutralizing antibodies (bnAbs). We engineered trispecific antibodies (Abs) that allow a single molecule to interact with three independent HIV-1 envelope determinants: the CD4 binding site, the membrane-proximal external region (MPER), and the V1V2 glycan site. Trispecific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
